Zhengye Biotechnology Holding Limited (ZYBT)

NASDAQ: ZYBT · Real-Time Price · USD

7.83

+0.22 (2.89%)

Aug 15, 2025, 9:46 AM - Market open

ZYBT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 15, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	371	-	-	-	-
Enterprise Value	370	-	-	-	-
Debt / Equity Ratio	0.25	0.25	0.27	0.18	0.09
Debt / EBITDA Ratio	2.13	2.13	1.30	0.77	0.44
Debt / FCF Ratio	3.15	3.15	2.20	-	2.35
Asset Turnover	0.38	0.38	0.42	0.54	-
Inventory Turnover	1.63	1.63	1.66	2.27	-
Quick Ratio	0.80	0.80	0.77	0.95	0.86
Current Ratio	1.31	1.31	1.26	1.41	1.31
Return on Equity (ROE)	3.89%	3.89%	10.78%	16.50%	-
Return on Assets (ROA)	2.07%	2.07%	5.51%	8.53%	-
Return on Capital (ROIC)	2.37%	2.37%	6.61%	10.68%	-
Return on Capital Employed (ROCE)	4.60%	4.60%	12.90%	17.90%	16.40%
Payout Ratio	-	141.66%	125.42%	45.84%	28.36%

Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q